Article
Introduction of an RS1 mutation causative variant consistent with identified XLRS patient using CRISPR/Cas9 technology in normal iPSC.
Stem cell research - 1 Dec 2024
Sun Xihao, Mao Shengru, Liang Yuqin, Duan Chunwen, Cui Zekai, Gu Jianing, Jiang Bing, Ding Chengcheng, Chen Jiansu, Tang Shibo
Abstract excerpt
X-linked retinoschisis (XLRS) is a common retinal genetic disease that occurs in juvenile males and causes progressive visual impairment. This presents a schisis in the macula or peripheral retina of bilateral eyes, which has no effective treatment. Here, we introduced the RS1 (c.C304T, p.R102W) mutation into a normal induced pluripotent stem (iPS) cell line using CRISPR/Cas9 technology. This missense mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
